Diabetic Nephropathy Suppliers In Asia Middle East

Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...

RheoMeditech Inc., founded in 2003, specializes in blood test in-vitro diagnostic device and has developed by publishing a number of technical and clinical papers to the international Association. RheoMeditech Inc. is a leading manufacturer of wide ...

DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...